Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Precursor in the synthesis of hydroquinone, ant...
VEGFR, PDGFR, c-Kit inhibitor.
Semi-synthetic vinca alkaloid found in Catharan...
Bulgarialactone azaphilone
Steroid sulfatase inhibitor.
Proteasome inhibitor.
Kavalactone originally found in Piper methystic...
Lipopeptide; 1,3-β-Glucan synthase inhibitor.<...
Polypeptide; peptidoglycan inhibitor.
Tetracycline; protein translation inhibitor, MM...
Endogenous peptide hormone; motilin agonist.
c-MET, Tie-2, VEGFR inhibitor.
Folate analog; thymidylate synthase inhibitor.<...
Agonist of STING.
Endogenous peptide, involved in hormone regulat...
Histamine H1 antagonist.
Podophyllotoxin derivative found in Podophyllum...
GPR84 agonist.
FIASMA, SERT and DAT inhibitor, α1-adrenergic ...
STING inhibitor